AP2015008748A0 - Stable dispersible formulation of arterolane maleate and piperaquine and process of preparation thereof - Google Patents
Stable dispersible formulation of arterolane maleate and piperaquine and process of preparation thereofInfo
- Publication number
- AP2015008748A0 AP2015008748A0 AP2015008748A AP2015008748A AP2015008748A0 AP 2015008748 A0 AP2015008748 A0 AP 2015008748A0 AP 2015008748 A AP2015008748 A AP 2015008748A AP 2015008748 A AP2015008748 A AP 2015008748A AP 2015008748 A0 AP2015008748 A0 AP 2015008748A0
- Authority
- AP
- ARIPO
- Prior art keywords
- piperaquine
- preparation
- dispersible formulation
- stable dispersible
- arterolane
- Prior art date
Links
- BRJULSXZDFYSPG-MSMJXPJBSA-N CC(C)(N)NC(=O)C[C@H]1CC[C@]2(CC1)OOC1(O2)[C@H]2CC3CC(C2)C[C@H]1C3 Chemical compound CC(C)(N)NC(=O)C[C@H]1CC[C@]2(CC1)OOC1(O2)[C@H]2CC3CC(C2)C[C@H]1C3 BRJULSXZDFYSPG-MSMJXPJBSA-N 0.000 title 1
- 229950007854 arterolane Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- UCRHFBCYFMIWHC-UHFFFAOYSA-N piperaquine Chemical compound ClC1=CC=C2C(N3CCN(CC3)CCCN3CCN(CC3)C=3C4=CC=C(C=C4N=CC=3)Cl)=CC=NC2=C1 UCRHFBCYFMIWHC-UHFFFAOYSA-N 0.000 title 1
- 229950006717 piperaquine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN587DE2013 | 2013-02-28 | ||
| PCT/IB2014/059317 WO2014132226A1 (en) | 2013-02-28 | 2014-02-27 | Stable dispersible formulation of arterolane maleate and piperaquine and process of preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AP2015008748A0 true AP2015008748A0 (en) | 2015-09-30 |
Family
ID=50382504
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AP2015008748A AP2015008748A0 (en) | 2013-02-28 | 2014-02-27 | Stable dispersible formulation of arterolane maleate and piperaquine and process of preparation thereof |
Country Status (2)
| Country | Link |
|---|---|
| AP (1) | AP2015008748A0 (en) |
| WO (1) | WO2014132226A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201013A (en) * | 2017-10-13 | 2020-05-26 | 研究三角协会 | Hydroxychloroquine sulfate formulations and methods of making and using same |
| CN116322688A (en) * | 2020-08-14 | 2023-06-23 | 太阳制药工业有限公司 | Fixed-dose combinations for the treatment of malaria |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006123314A2 (en) * | 2005-05-18 | 2006-11-23 | Ranbaxy Laboratories Limited | Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials |
| KR20140053169A (en) | 2011-07-14 | 2014-05-07 | 랜박시 래보러터리스 리미티드 | Stable dosage forms of arterolane and piperaquine |
-
2014
- 2014-02-27 AP AP2015008748A patent/AP2015008748A0/en unknown
- 2014-02-27 WO PCT/IB2014/059317 patent/WO2014132226A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2014132226A1 (en) | 2014-09-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL241878B (en) | Macrolides and methods of their preparation and use | |
| PL2986452T3 (en) | Dispersible articles and methods of making the same | |
| IL235831A0 (en) | Novel dosage form and formulation of abediterol | |
| ZA201602770B (en) | Tyrosine derivatives and compositions comprising them | |
| PT3021839T (en) | Methods and compositions for treatment of fibrosis | |
| IL234841A0 (en) | Dosage forms of halofuginone and methods of use | |
| IL240227A0 (en) | Immunogenic compositions comprising silicified virus and methods of use | |
| EP2827822A4 (en) | Adjustable bedding foundation and process of making same | |
| EP3073871A4 (en) | Novel functionally supportive pillows and methods of preparation thereof | |
| SG11201507978XA (en) | Vaccine composition and method of use | |
| IL245529A0 (en) | Rapidly disintegrating formulations and methods of use | |
| EP3062853A4 (en) | Improvements to small-volume nebulizers and methods of use thereof | |
| SG11201507389RA (en) | Integration of hydro-dechlorination and hydro-regeneration | |
| SG11201602501VA (en) | Hiv treatment formulation of atazanavir and cobicistat | |
| EP2986112A4 (en) | Preparation and use of fulvic acid derivatives | |
| EP2994147A4 (en) | Compositions and methods for the treatment of tinnitus | |
| GB201307082D0 (en) | Pharmaceutical composition comprising 15-HETrE and methods of using the same | |
| AP2015008748A0 (en) | Stable dispersible formulation of arterolane maleate and piperaquine and process of preparation thereof | |
| EP2945703A4 (en) | Formulations of albu-bche, preparation and uses thereof | |
| EP3055678A4 (en) | Challenge sets and methods of making and using the same | |
| GB201312375D0 (en) | Microemulsion formulation and method of manufacture | |
| ZA201508951B (en) | Polymorph forms of icotinib maleate and uses thereof | |
| AU2013904774A0 (en) | Methods and Preparation and Use of Xanthorrhoeaceae Compositions | |
| SG11201509750VA (en) | Polymorph forms of icotinib maleate and uses thereof | |
| HK1229662A1 (en) | Novel functionally supportive pillows and methods of preparation thereof |